Format

Send to

Choose Destination
Expert Rev Respir Med. 2011 Apr;5(2):145-52. doi: 10.1586/ers.11.14.

Inhaled iloprost for therapy in pulmonary arterial hypertension.

Author information

1
Department of Internal Medicine, Ernst-Moritz-Arndt University, Greifswald, Germany.

Abstract

Iloprost (Ventavis, Bayer Schering Pharma, Germany) is a synthetic prostacyclin that is used in its inhalative form for the therapy of pulmonary arterial hypertension. Long-term therapy can increase exercise capacity and quality of life. The use of modern nebulizers especially designed for the administration of iloprost guarantees the pulmonary deposition of the required doses and systematically minimizes side effects. Regarding existing data, inhalative iloprost acts in effective and safe combination with other classes of medication; indeed, such combination therapy is frequently necessary in pulmonary arterial hypertension.

PMID:
21510725
DOI:
10.1586/ers.11.14
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center